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ABSTRACT 
The aim of this study was to obtain an accurate estimate of diabetes prevalence in Croatia and 
additional estimates of impaired fasting glucose (IFG), undiagnosed diabetes and insulin 
resistance. 
The study was part of the First Croatian Health Project. Field work included a questionnaire, 
anthropological measurements and blood sampling. A nationally representative sample of 1,653 
subjects aged 18-65 years was analyzed.  
A total of 100 participants with diabetes were detected, among them 42 with previously unknown 
diabetes. The prevalence was 6.1% (95%CI:4.59-7.64), with a significant difference by age. IFG 
prevalence (WHO-criteria) was 11.3%. The ratio of undiagnosed/diagnosed diabetes was 72/100, 
unevenly distributed by the regions. HOMA-IR was >1 in 40.4% of the subjects.  
This survey revealed a higher prevalence of diabetes than previously estimated, whereas that of 
IFG was as expected. A significant difference in the proportion of undiagnosed diabetes among 
the regions warrants attention.  
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1. INTRODUCTION 
Diabetes mellitus (DM) is a major public health problem worldwide [1]. Although its prevalence 
has been used as one of the parameters in the assessment of the quality of health care by the 
World Health Organization (WHO) [2], surveys have been conducted in only a limited number of 
countries [3]. The prevalence of type 2 diabetes increases with that of obesity. This increase in 
the number of people with diabetes will lead to unforeseen and unsustainable costs in most of the 
countries of the world [1]. In Croatia, diabetes prevalence has been estimated according to data 
from questionnaires completed by diabetes centers [4]. However, as these were not survey data, 
the estimates of diabetes prevalence in Croatia as reported in the International Diabetes 
Federation (IDF) atlas [5,6] have been made by extrapolating data from similar populations [7,8].  
The aim of the present study was to obtain an accurate estimate of diabetes prevalence in Croatia. 
Its additional aims were to estimate the percentage of impaired fasting glucose (IFG), 
undiagnosed diabetes, and the prevalence of insulin resistance (IR) in the country. It was the first 
Croatian survey targeting diabetes prevalence. The study was part of the First Croatian Health 
Project [9], preliminary data of which had been reported earlier [10]. 
 
2. PARTICIPANTS, MATERIALS AND METHODS 
The design of the First Croatian Health Project has been described previously [9]. In short, a 
large field study was performed from 1995 to 1997 in 10,074 participants aged 18-80 years from 
30 communities of 4 geographical regions: two continental (Osijek and Zagreb) and two 
Mediterranean ones (Rijeka and Split). All personnel involved in the field work (physicians, 
nurses and laboratory technicians) underwent a training program before its onset. The field work 
consisted of questionnaires completion, blood pressure, weight and height measurements, and 
venous blood sampling. The questionnaire asked respondents about their personal and family 
history of chronic noncommunicable diseases including diabetes. Completed questionnaires, 
respondents’ record forms and frozen blood samples were delivered to the Center for 
Coordination. Samples were stored at -200C within 30 minutes. A representative sample of 5,840 
randomly selected participants aged 18-65 yrs with age, gender and regional distribution identical 
to the national population was created for analysis. More than 97% of the Croatian population are 
white Europeans [11].  
2.1 Defining the sample for diabetes prevalence subanalysis. Before performing a subanalysis 
on diabetes prevalence, sample size was estimated with allowed relative error of 2%, a 99% 
confidence interval, and an assumed diabetes prevalence lower than 10% [12] . Data from 1635 
subjects were analyzed. The representativeness of the sample was confirmed by statistical 
analyses revealing no differences in age, gender and regional distribution between this sample 
(N=1635) and the original stratified one from The First Project (n=5840) (ANOVA p<0.01). 
There were 814 female and 821 male participants with mean age of 41.49 years (41.49 ± 12.18) 
and no difference between women and men (women 42.03±14.44, men 41.35±12.41; p>0.01, t-
test). The research was performed in small towns with mixed urban and semi-urban population. 
All participants signed an informed consent and the whole study was approved by the Central 
Research Ethics Committee. 
2.2 Assessment of diabetes. Subjects who reported having diabetes and those taking oral 
hypoglycemic agents or insulin were considered as persons with previously diagnosed diabetes. 
Those with no such history but with fasting blood glucose (FBG) of 7 mmol/l or above were 
considered to have previously unknown diabetes. According to the WHO criteria, the participants 
without previous history of diabetes and with FBG greater than 6.1 and lower than 7.0 mmol/l 
were diagnosed as having IFG [13]. 
2.3 FBG, fasting plasma insulin (FPI), body mass index (BMI) and IR assessment. Glucose 
and insulin concentrations were analyzed from frozen samples using standard methods: glucose 
oxidase was determined [14] (Thermo Trace, Noble Park, Victoria, Australia) on a 
spectrophotometer (AU 600 Olympus, Tokyo, Japan) and insulin was measured by a solid-phase 
radioimmunoassay (Diagnostic Products Corporation, Los Angeles, CA, USA), with a reference 
value of < 22 µU/l. The analyses were made centrally at the Vuk Vrhovac University Clinic 
laboratory with continuous external quality control [15]. Homeostasis model assessment insulin 
resistance index (HOMA-IR) was calculated as IR = insulin/ (22.5e -ln BG) to assess insulin 
resistance [16]. BMI was calculated as weight (kg) divided by the square of height (m).  
2.4 Statistical analyses. Variance homogeneity was tested using Lindman’s test prior to the 
analysis of correlation and between-group differences. Normality of distribution was tested using 
Shapiro-Wilk's W test. Differences between groups of independent variables were analyzed using 
t test (for two groups), ANOVA (for three or more groups of variables) and Bonferroni post hoc 
procedure. Differences in the prevalence of individual conditions were compared using chi2 test. 
The level of significance of correlation between variables and the correlation trend were analyzed 
by Pearson Correlation Test. Statistical significance was defined as a p value of 0.01 or less in all 
analyses, carried out using STATISTICA version 7.0. 
 
3. RESULTS 
Fifty-eight persons with previously known diabetes and 42 with previously unknown diabetes 
were detected based on the described criteria, yielding an estimated prevalence of 6.1% (95% 
confidence interval: 4.59-7.64) in the 18-64-year age group. The difference in diabetes 
prevalence was statistically significant by age, but not by gender and regions (Table 1).  
Among the subjects with no history of DM or drug therapy for diabetes there were 2.7% of those 
with FBG >7 mmol/L. The frequency of previously unknown DM was significantly higher in 
men compared to women (3.8% vs. 1.5%; chi2 p<0.001), with a significant increase in age (1.5% 
vs. 1.4% vs. 2.8% vs.  4.6%; chi2 p=0.013) and with an even regional distribution (3% vs. 2.5% 
vs. 1.8% vs. 2.9%; chi2 p=0.755) (Figure 1).  
In total, the calculated number of undiagnosed persons with diabetes to every 100 diagnosed was 
72 (31-114 per region). Distribution between different types of diabetes mellitus was not 
analyzed. 
There were 11.3% of subjects with FBG equal to or higher than 6.1 mmol/L and less than 7.0 
mmol/L (IFG) among those with no history of DM or receiving drug therapy for diabetes. The 
frequency was significantly higher in men than in women (14.6% vs. 7.9%), significantly 
increasing with age, and revealing significant differences among the studied regions (higher in 
the two continental regions (Osijek and Zagreb) than in the two Mediterranean ones (Rijeka and 
Split). (Figure 1).  
Subjects without a previous history of diabetes who were diagnosed with DM or IFG in this study 
had significantly higher BMI indices than individuals with normal FPG in both men (29.18 ± 
4.68 vs. 28.09 ± 4.06 vs. 26.53 ± 3.27; ANOVA p<0.001) and women (28.07 ± 5.21 vs. 28.42 ± 
4.50 vs. 25.10 ± 3.95; ANOVA p<0.001), whereas the difference in BMI indices between the 
subjects with DM and those with IFG was not significant. 
Mean FPI and FBG, and HOMA-IR index are shown in Table 2. Insulin concentrations were 
significantly higher in men as compared to women (p<0.01, chi2 test). HOMA-IR greater than 1 
was present in as much as 40.4% of the subjects, significantly more frequently in men than in 
women (p<0.01, chi2 test) and in higher BMI categories (p<0.01, chi2 test), with an uneven 
distribution per regions (p<0.01, chi2 test). Correlation between BMI, FBG, IR and age was 
revealed for the entire sample as well as for women and men separately (Pearson's, p<0.01). 
ANOVA revealed significant differences in FBG by age, gender and region (p<0.01), and the 
interaction of age and region (p<0.01). A significant difference in FPI was revealed by age 
(p<0.01) and the interaction between age and region (p<0.01), but not by gender (p=0.06) or 
region (p=0.04). For HOMA-IR the difference was significant by age, gender and region as well 
as by the interaction of age and region (p<0.01). 
 
4. DISCUSSION 
The results of this study revealed a higher diabetes prevalence in Croatia than estimated by the 
IDF atlas from 2000 [6], comparable to the IDF atlas estimates from 2006 [3]. The present results 
would be expected to be comparable to the 2000 estimate, as the survey was conducted in the 
period from 1995 to 97. It is possible that the study [17] used for the 2006 estimate was carried 
out in a population more similar to the Croatian one and using a more appropriate methodology. 
The achieved prevalence of diabetes in Croatia was shown to be higher than estimates for Croatia 
and the neighbouring countries (Bosnia and Herzegovina 3.4 % and Slovenia 4.3 % for the 20-
65-year age groups) published by King et al. [1] The more recent prevalence estimates have been 
higher in the older age group as well (Bosnia and Herzegovina 9.6%, Slovenia 9.6 % for the 20-
79-year age groups) [3]. The difference could also be explained by the different method used 
(OGTT compared to fasting plasma glucose in our study).  
The real prevalence of diabetes can be presumed to be somewhat higher, as OGTT was not 
performed in our study, and so persons with diagnostically significant 2-hour post-load glucose 
values remained undiagnosed. Two-hour value is less reproducible than FBG [18], which is why 
the methodology used (a questionnaire and FBG) is considered sufficient for epidemiological 
purposes [13]. It has been shown that FPG alone underestimates the prevalence of diabetes in 
women and elderly men of European descent [19,20,21]. Hence, without data obtained by OGTT, 
the obtained prevalence can be hypothesized to be somewhat underestimated [22]. The 
prevalence in women in this study did not significantly differ from that in men.  
The high prevalence of diabetes in Europe might be associated with relative poverty, as suggested 
by the results of a study in a British inner city [23]. The average annual household income in 
Croatia was less than 15,000 US$ in the observed period [24], which is comparable to the low-
income households in the developed European countries [23]. This might in part account for a 
seemingly higher diabetes prevalence in Croatia, and would be interesting to examine across 
comparable transitional economies. On a global level, a huge increase in diabetes prevalence is 
expected [25], for which reason further periodic surveys should be carried out in Croatia on a 
regular basis.  
Although a small country, Croatia has natural regional differences: a part of the country is 
Mediterranean, while the other part is continental. Diabetes prevalence was not different among 
the regions although there were significant differences in FBG by age, gender and region. 
There were 11.3% of participants with IFG, which was more frequent in men than in women 
(14.6% vs. 7.9%), significantly increasing with age. The overall prevalence of IFG was lower 
than that reported for the US [26] and higher than the prevalence from an Indian study [27], being 
in range with recent studies on the population of Iran [28].  
However, it is interesting to note that the prevalence of IFG showed an uneven regional 
distribution, being lower in the Mediterranean regions than in the continental ones, although the 
same pattern was not observed for the prevalence of diabetes.  
The high proportion of undiagnosed persons with diabetes is comparable to the average of 0.7 
obtained from thirteen European studies from the DECODE Study [20] and the one from 
Denmark [29]. The proportion of undiagnosed persons was higher in men and lower in older and 
obese individuals, as reported in most studies [18,20,29,30]. As these data depend on various 
factors, there might even be as many as 150 undiagnosed patients with DM to every 100 
diagnosed individuals with diabetes [31]. 
A significant difference in the proportion of undiagnosed diabetes within Croatian regions 
warrants attention. It might reflect an uneven awareness of diabetes in the country, pointing to the 
need for regional educational programs for health care professionals. 
As expected from the previously published data on the impact of overweight on the development 
of diabetes [32] and on BMI in diabetic patients [33], BMI indices were found to be higher in the 
subjects with newly diagnosed DM and IFG than in those with normal FPG. 
HOMA-IR > 1 was found in as much as 40.4% of the respondents, significantly more frequently 
in men than in women and in higher BMI categories, the correlation between BMI, FBG, IR and 
age being as expected. 
The prevalence of persons with HOMA-IR index greater than 1 was unevenly distributed: it was 
higher in one continental and one Mediterranean region (Osijek region: 61.6% and Rijeka region: 
59.6%) and lower in the other pair (Zagreb region: 28.0% and Split region: 27.6%). In spite of 
the 40.4 percent prevalence, HOMA-IR index was lower than that in the previously published 
studies [34].  
The results of this survey revealed a higher prevalence of diabetes in Croatia than previously 
estimated, whereas that of impaired fasting glucose was as expected. A significant difference in 
the proportion of undiagnosed persons with diabetes among the geographic regions warrants 
further attention. 
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TABLES AND FIGURES 
 
FIGURE LEGENDS 
 
Figure 1: Diabetes and impaired fasting glucose in persons with no previous history of diabetes 
as percentage of participants.  
 
Table 1: Diabetes prevalence and differences in prevalence according to gender, age and region 
 
 prevalence (%) 99% CI p value 
overall 6.1 4.59-7.64 - 
gender   0.122 
men 7.1 4.76-9.37  
women 5.2 3.16-7.16  
age   p<0.01 
18-29 1.9 0.37-5.75  
30-39 2.0 0.38-3.63  
40-49 6.9 3.68-10.21  
50-65 12.1 8.25-16.01  
region   0.690 
Osijek 6.7 3.73-9.58  
Rijeka 5.9 2.51-10.18  
Split 7.1 3.24-10.9  
Zagreb 5.3 2.85-7.66  
 
 
Table 2: Mean fasting plasma insulin (FPI) and glucose (FPG) concentrations, and mean HOMA 
insulin resistance indexes (HOMA-IR), with standard deviation (SD) 
 
TOTAL 
N=1635 
men 
N =821 
women 
N =814 
 
mean SD mean SD mean SD 
FPI 6.72 8.55 7.12 8.92 6.32 8.14 
FBG 5.03 1.40 5.18 1.51 4.83 1.25 
HOMA-IR 1.45 2.38 1.58 2.53 1.31 2.22 
 
 
